ArticleNature biotechnology2018

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.

Todd A Triplett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.